Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 50Lymphoma, Non-Hodgkin 45Lymphoma 34Lymphoma, Mantle-Cell 30Lymphoma, Follicular 26Multiple Myeloma 23Hodgkin Disease 21Lymphoma, Large B-Cell, Diffuse 18Recurrence 13Lymphoma, B-Cell, Marginal Zone 12Leukemia 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Neoplasms 6Lymphoma, T-Cell 5Waldenstrom Macroglobulinemia 4Lymphoma, Large-Cell, Anaplastic 4Lymphoma, B-Cell 4Leukemia, Myeloid, Acute 4Leukemia, B-Cell 4Breast Neoplasms 4Small Cell Lung Carcinoma 3Sezary Syndrome 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms, Plasma Cell 3Myelodysplastic Syndromes 3Mycosis Fungoides 3Lymphoma, T-Cell, Peripheral 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Extranodal NK-T-Cell 3Immunoblastic Lymphadenopathy 3

Interventions

Rocuronium 2ziprasidone 1perflutren 1peginesatide 1hematide 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tranexamic Acid 1Tobramycin 1Thalidomide 1Spironolactone 1Sevelamer 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nifedipine 1Nafcillin 1Molindone 1Methylprednisolone 1Lurasidone Hydrochloride 1Labetalol 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1High-Energy Shock Waves 1Haloperidol 1Fosfomycin 1Dexamethasone 1DM199 1Clozapine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Renal Insufficiency, Chronic × Bendamustine Hydrochloride × Clear all
NCT02424851 2022-01-27

OPTIMAL

Oxford University Hospitals NHS Trust

Phase 2 Completed
31 enrolled 13 charts
Plasma cell

Multiple Myeloma, Renal Insufficiency, Chronic, Renal Insufficiency, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡